ScoreWhy is Nutex Health, Inc. ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.16 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 229.14%
3
The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 177.78 MM
- NET PROFIT(Q) At USD 55.44 MM has Grown at 246.56%
- ROCE(HY) Highest at 63.86%
4
With ROE of 83.15%, it has a attractive valuation with a 2.04 Price to Book Value
- Over the past year, while the stock has generated a return of 62.24%, its profits have risen by 5011.1%
5
High Institutional Holdings at 46.01%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Nutex Health, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Nutex Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Nutex Health, Inc.
62.24%
13.29
116.67%
S&P 500
13.5%
0.70
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
229.14%
EBIT Growth (5y)
125.47%
EBIT to Interest (avg)
3.68
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
2.36
Tax Ratio
18.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
46.01%
ROCE (avg)
65.61%
ROE (avg)
55.87%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
2.04
EV to EBIT
1.50
EV to EBITDA
1.42
EV to Capital Employed
2.57
EV to Sales
0.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
171.58%
ROE (Latest)
83.15%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend40What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 177.78 MM
NET PROFIT(Q)
At USD 55.44 MM has Grown at 246.56%
ROCE(HY)
Highest at 63.86%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -111.89% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 60.71 %
INVENTORY TURNOVER RATIO(HY)
Highest at 162.97 times
NET SALES(Q)
Highest at USD 267.8 MM
OPERATING PROFIT(Q)
Highest at USD 135.37 MM
OPERATING PROFIT MARGIN(Q)
Highest at 50.55 %
PRE-TAX PROFIT(Q)
Highest at USD 123.94 MM
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Nutex Health, Inc.
Net Profit
At USD 55.44 MM has Grown at 246.56%
over average net sales of the previous four periods of USD 16 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 177.78 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
At USD 267.8 MM has Grown at 35.22%
over average net sales of the previous four periods of USD 198.05 MMMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 123.94 MM has Grown at 137.54%
over average net sales of the previous four periods of USD 52.18 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Sales
Highest at USD 267.8 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 135.37 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 50.55 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 123.94 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Debt-Equity Ratio
Lowest at 60.71 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 162.97 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -111.89% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
